4//SEC Filing
Hunter Heidi 4
Accession 0001209191-21-066150
CIK 0001382101other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 5:29 PM ET
Size
8.1 KB
Accession
0001209191-21-066150
Insider Transaction Report
Form 4
Hunter Heidi
Director
Transactions
- Award
Stock Option (right to buy Common Stock)
2021-11-19+24,000→ 24,000 totalExercise: $17.56Exp: 2031-11-18→ Common Stock (24,000 underlying) - Award
Stock Option (right to buy Common Stock)
2021-11-19+9,884→ 9,884 totalExercise: $17.56Exp: 2031-11-18→ Common Stock (9,884 underlying)
Footnotes (2)
- [F1]The option vests as to 2.778% of the total shares monthly, beginning on December 19, 2021, with 100% of the total shares vested and exercisable on November 19, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]The option vests as to 15.59% of the total shares monthly beginning on December 19, 2021 through May 19, 2022, and 6.45% on June 2, 2022, with 100% of the total shares vested and exercisable on the issuer's 2022 annual meeting of stockholders, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001891841
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 5:29 PM ET
- Size
- 8.1 KB